No approval for Covaxin, expert panel seeks more data from Bharat Biotech

Earlier on Friday, the expert committee, which is tasked with vetting covid-19 vaccine proposals, recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It become the first vaccine to secure recommendation for emergency use in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3o4Bi1e
via IFTTT